173 related articles for article (PubMed ID: 24129965)
1. Daikenchuto, a traditional Japanese herbal medicine, for the maintenance of surgically induced remission in patients with Crohn's disease: a retrospective analysis of 258 patients.
Kanazawa A; Sako M; Takazoe M; Tadami T; Kawaguchi T; Yoshimura N; Okamoto K; Yamana T; Sahara R
Surg Today; 2014 Aug; 44(8):1506-12. PubMed ID: 24129965
[TBL] [Abstract][Full Text] [Related]
2. Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn's disease: a single-center paired case-control study.
Araki T; Uchida K; Okita Y; Fujikawa H; Inoue M; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Surg Today; 2014 Feb; 44(2):291-6. PubMed ID: 23463537
[TBL] [Abstract][Full Text] [Related]
3. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
[TBL] [Abstract][Full Text] [Related]
4. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Hanauer SB; Korelitz BI; Rutgeerts P; Peppercorn MA; Thisted RA; Cohen RD; Present DH
Gastroenterology; 2004 Sep; 127(3):723-9. PubMed ID: 15362027
[TBL] [Abstract][Full Text] [Related]
5. [Reoperation rate and related factors in patients with Crohn's disease].
Guo MY; Sun XY; Wu B; Chen XF; Zhang HM; Zhang MM; Zhou RN; Zhou QY; Ruan GC; Bai XY; Yang H
Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(22):1683-1689. PubMed ID: 34126717
[No Abstract] [Full Text] [Related]
6. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Naidoo K; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Ardizzone S; Maconi G; Sampietro GM; Russo A; Radice E; Colombo E; Imbesi V; Molteni M; Danelli PG; Taschieri AM; Bianchi Porro G
Gastroenterology; 2004 Sep; 127(3):730-40. PubMed ID: 15362028
[TBL] [Abstract][Full Text] [Related]
8. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
Riss S; Schuster I; Papay P; Mittlböck M; Stift A
Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
[TBL] [Abstract][Full Text] [Related]
9. Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn's Disease?
Bolckmans R; Kalman T; Singh S; Ratnatunga KC; Myrelid P; Travis S; George BD
Dis Colon Rectum; 2020 Feb; 63(2):200-206. PubMed ID: 31842162
[TBL] [Abstract][Full Text] [Related]
10. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of symptomatic remission in patients with Crohn's disease.
Stark ME; Tremaine WJ
Mayo Clin Proc; 1993 Dec; 68(12):1183-90. PubMed ID: 7902474
[TBL] [Abstract][Full Text] [Related]
12. Current treatment for prevention of relapse and recurrence in Crohn's disease.
Prantera C; Scribano ML
Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
[TBL] [Abstract][Full Text] [Related]
13. Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine.
Ren J; Wu X; Liao N; Wang G; Fan C; Liu S; Ren H; Zhao Y; Li J
J Int Med Res; 2013 Feb; 41(1):176-87. PubMed ID: 23569144
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with postoperative recurrence and repeat surgery in Japanese patients with Crohn's disease.
Kusaka J; Shiga H; Kuroha M; Kimura T; Kakuta Y; Endo K; Kinouchi Y; Shimosegawa T
Int J Colorectal Dis; 2017 Oct; 32(10):1407-1413. PubMed ID: 28735411
[TBL] [Abstract][Full Text] [Related]
16. Enteral nutrition to suppress postoperative Crohn's disease recurrence: a five-year prospective cohort study.
Yamamoto T; Shiraki M; Nakahigashi M; Umegae S; Matsumoto K
Int J Colorectal Dis; 2013 Mar; 28(3):335-40. PubMed ID: 23014978
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
[TBL] [Abstract][Full Text] [Related]
18. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
Caprilli R; Corrao G; Taddei G; Tonelli F; Torchio P; Viscido A
Dis Colon Rectum; 1996 Mar; 39(3):335-41. PubMed ID: 8603558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
